EN
登录

Nagase Viita推出SOLBIOTE(TM),用于生物制药的新型可注射级糖精辅料

Nagase Viita Launches SOLBIOTE (TM), New Brand of Injectable-grade Saccharide Excipients for Biopharmaceuticals

CISION 等信源发布 2024-06-10 15:23

可切换为仅中文


OKAYAMA, Japan, June 10, 2024 /PRNewswire/ -- Nagase Viita Co., Ltd., a member of the NAGASE Group headquartered in Okayama Japan, has launched a new product brand, SOLBIOTE (TM), featuring its saccharide-based pharmaceutical excipients of high-purity and low-endotoxin TREHALOSE SG and MALTOSE PH.

日本冈山,2024年6月10日/PRNewswire/--长濑集团(总部位于日本冈山)的成员长濑维塔株式会社(Nagase Viita Co.,Ltd.)推出了一个新产品品牌SOLBIOTE(TM),其特点是其糖类药物赋形剂具有高纯度和低内毒素海藻糖SG和麦芽糖PH。

SOLBIOTE (TM) portfolio is an excellent protein stabilizer, protecting cells, nucleotides, and exosomes from various damage caused by stressors such as drying, freezing, and thawing. It preserves the quality of antibody therapeutics, vaccines, and other biopharmaceuticals, which are inherently unstable during manufacturing, storage, and distribution, requiring adequate cold-chain management..

SOLBIOTE(TM)portfolio是一种出色的蛋白质稳定剂,可保护细胞,核苷酸和外泌体免受干燥,冷冻和解冻等应激因素引起的各种损伤。它保留了抗体治疗剂,疫苗和其他生物制药的质量,这些药物在制造,储存和分销过程中本质上是不稳定的,需要足够的冷链管理。。

Image1: SOLBIOTE (TM) portfolio; TREHALOSE SG and MALTOSE PH https://cdn.kyodonewsprwire.jp/prwfile/release/M104815/202406031668/_prw_PI1fl_MyQw9rBz.jpg

图1:SOLBIOTE(TM)投资组合;海藻糖SG和麦芽糖PHhttps://cdn.kyodonewsprwire.jp/prwfile/release/M104815/202406031668/_prw_PI1fl_MyQw9rBz.jpg

Nagase Viita has a long history of harnessing the power of nature and an expertise in biotechnology, which led it to be the first to successfully mass produce trehalose utilizing starch and enzymes. It is committed to providing a stable supply of safe, high-quality excipients through its integrated manufacturing from saccharide production to refining..

长濑威塔在利用大自然的力量和生物技术方面拥有悠久的历史,这使它成为第一个利用淀粉和酶成功大规模生产海藻糖的公司。它致力于通过从糖类生产到精炼的一体化制造,提供安全、优质的赋形剂稳定供应。。

The company will further pursue the development of new saccharide excipients for the SOLBIOTE (TM) portfolio and its advanced pharmaceutical applications, bringing pharmaceutical solutions for universal health.

该公司将进一步为SOLBIOTE(TM)产品组合及其先进的药物应用开发新的糖类赋形剂,为全民健康带来药物解决方案。

Image2: Image of SOLBIOTE (TM) https://cdn.kyodonewsprwire.jp/prwfile/release/M104815/202406031668/_prw_PI2fl_hrz1tewp.jpg

图2:SOLBIOTE(TM)的图像https://cdn.kyodonewsprwire.jp/prwfile/release/M104815/202406031668/_prw_PI2fl_hrz1tewp.jpg

The name SOLBIOTE (TM) comes from 'Sol + Bio,' developed by the company's Biotechnology and starch, a gift from the sun (Sol meaning the sun in Latin), providing Solutions to Biopharmaceuticals.

SOLBIOTE(TM)的名字来自“Sol+Bio”,由该公司的生物技术和淀粉开发,这是太阳(Sol在拉丁文中的意思是太阳)的礼物,为生物制药提供解决方案。

For further details, visit: https://group.nagase.com/viita/en/products_solutions/pharmaceutical_ingredients/

有关更多详细信息,请访问:https://group.nagase.com/viita/en/products_solutions/pharmaceutical_ingredients/